PAVmed Inc. PAVM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -89.02% | -95.74% | -97.63% | -99.28% | -73.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -89.02% | -95.74% | -97.63% | -99.28% | -73.36% |
| Cost of Revenue | -76.16% | -91.12% | -95.52% | -97.19% | -77.85% |
| Gross Profit | 49.18% | 83.04% | 92.08% | 93.62% | 83.64% |
| SG&A Expenses | -10.46% | -35.86% | -52.51% | -61.94% | -49.97% |
| Depreciation & Amortization | -- | -- | -- | -100.00% | -94.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.04% | -35.38% | -53.92% | -66.14% | -55.96% |
| Operating Income | 0.82% | 32.03% | 50.98% | 63.74% | 54.85% |
| Income Before Tax | -124.11% | -133.79% | -108.69% | -85.52% | 193.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -124.11% | -133.79% | -108.69% | -85.52% | 193.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -8.15% | -58.03% | -74.74% | -88.48% | -68.16% |
| Net Income | -116.59% | -125.18% | -98.99% | -87.28% | 226.20% |
| EBIT | 0.82% | 32.03% | 50.98% | 63.74% | 54.85% |
| EBITDA | -0.27% | 31.00% | 49.86% | 62.78% | 53.64% |
| EPS Basic | -106.42% | -117.51% | -90.48% | -41.54% | 186.77% |
| Normalized Basic EPS | 92.85% | 93.77% | 91.99% | 92.46% | 84.38% |
| EPS Diluted | -158.74% | -328.11% | 65.22% | 83.80% | 112.61% |
| Normalized Diluted EPS | 71.61% | 89.74% | 94.67% | 97.14% | 96.07% |
| Average Basic Shares Outstanding | 437.81% | 159.73% | 107.79% | 79.35% | 58.37% |
| Average Diluted Shares Outstanding | 15.03% | -52.11% | -38.77% | 218.30% | 640.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |